Contract Service Directory


AbbVie Contract Manufacturing





Company Headquarters

1401 Sheridan Road
North Chicago, IL 60064
United States

Company Description

AbbVie, world leader in pharmaceuticals, provides Contract Manufacturing Services that span custom and bulk API manufacturing, aseptic fill finish, oral solid dose, biologics, potent, finishing and packaging of pharmaceutical drug products. Our vast network of global manufacturing facilities allows our partners to customize their contract manufacturing services from global to regional production needs. We work with partners who value quality healthcare as much as we do.

Contract Service Directory

    Related Content

    • Breaking News | Promotions & Moves | Solid Dosage/Creams/Ointments
      Recro Expands Board of Directors

      Recro Expands Board of Directors

      Welcomes Dr. Laura L. Parks to the board.
      06.16.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
      Dendreon Pharmaceuticals Establishes Contract Manufacturing Division

      Dendreon Pharmaceuticals Establishes Contract Manufacturing Division

      Now offers end-to-end manufacturing of complex cell therapies and patient logistics for partner programs.
      06.15.21

    • Breaking News | Facilities | Industry News | Packaging & Tracking
      Bushu Pharma Establishes Packaging Center

      Bushu Pharma Establishes Packaging Center

      Expands its gateway to Asia services in partnership with Chuo Unyu Company.
      Charles Sternberg, Assistant Editor 04.29.21


    • Biologics, Proteins, Vaccines | Breaking News | Industry News
      Thermo Fisher Buys Novasep

      Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

      Pays more than $800 million to expand global capacity and address growing demand for cell and gene therapy.
      Contract Pharma Staff 01.15.21

    • Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      Fujifilm to Invest $40M in New Facility

      Fujifilm to Invest $40M in New Facility

      State-of-the-art viral vector and advanced therapy process development and manufacturing facility will be located in Boston area.
      Contract Pharma Staff 01.05.21

    • Bio News | Breaking News | cGMP Manufacture | Industry News
      eTheRNA Extends mRNA Production Services

      eTheRNA Extends mRNA Production Services

      Adds high throughput research grade mRNA to its GMP capabilities.
      Contract Pharma Staff 11.03.20


    • Breaking News | Collaborations & Alliances | Supply Chain
      Schreiner MediPharm, PragmatIC Form Partnership for Smart Pharma Labels

      Schreiner MediPharm, PragmatIC Form Partnership for Smart Pharma Labels

      New RFID-labels ideal for broad array of pharmaceutical products and medical devices.
      Schreiner MediPharm 12.11.19

    • Breaking News | cGMP Manufacture | Industry News
      Thermo Fisher Opens $90M Viral Vector Mfg. Site

      Thermo Fisher Opens $90M Viral Vector Mfg. Site

      The facility will create 200 new jobs and support the development, testing and manufacture of viral vectors.
      12.05.19

    • Frontage Laboratories

      Frontage Laboratories' Hugh Davis

      Frontage's chief business officer highlights the CRO's service offerings.
      Contract Pharma Staff


    • Catalent

      Catalent's Stacey Treichler

      Catalent's product manager for biologics highlights key events.
      Contract Pharma Staff

    • German Pharma Benefiting From a Brexit Boost?

      German Pharma Benefiting From a Brexit Boost?

      Germany consolidates itself as world leader in pharma according to the CPhI Pharma Index.
      10.29.19

    • Breaking News | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
      Catalent, Acura Enter Clinical Manufacturing Pact

      Catalent, Acura Enter Clinical Manufacturing Pact

      Catalent to scale-up manufacturing of LTX-03 for clinical testing
      09.16.19


    • Critical Factors of Fill Finish Manufacturing For Biologics

      Critical Factors of Fill Finish Manufacturing For Biologics

      The bulk drug substance, formulation, and sterile filtering and filling of the final drug product all require special handling procedures.

    • Biologics, Proteins, Vaccines | Drug Delivery | Injectables
      Growth in Biologics and Maintaining Patient Satisfaction

      Growth in Biologics and Maintaining Patient Satisfaction

      Vicki A. Barbur of Battelle discusses the driving forces for biologics, the challenges, and new delivery methods
      Kristin Brooks, Contrct Pharma 08.09.19

    • Trials & Filings
      La Jolla Pharma Receives Orphan Designation for Malaria Treatment

      La Jolla Pharma Receives Orphan Designation for Malaria Treatment

      LJPC-0118, artesunate, demonstrated to be superior to quinine in reducing mortality in patients with falciparum malaria infection
      07.23.19

    • Industry News | Supply Chain
      Cobra Biologics and Symbiosis Complete Viral Vector Supply Chain

      Cobra Biologics and Symbiosis Complete Viral Vector Supply Chain

      Develops capabilities intended to accelerate the clinical and commercial production of viral vectors
      06.25.19

    • Industry News
      AbbVie at Contracting & Outsourcing 2018

      AbbVie at Contracting & Outsourcing 2018

      Ania VanDyke, Associate Director of Business Development, details the company's contract manufacturing offerings

    • Leadership Perspective: CDMO/Sponsor Partnerships

      Leadership Perspective: CDMO/Sponsor Partnerships

      Keith Kentala of AbbVie Contract Manufacturing offers his thoughts on the value CDMOs bring to their customers
      Keith Kentala, Vice President, Commercial Operations, AbbVie Contract Manufacturing 01.26.18